ALKERMES | 净收入

金融业

USD

USD 2.33B

现金及等价物

USD 616.45M

USD 51.59M

USD 1.74B

USD 474.36M

USD 71.6M

股息收益率

0

USD 89.08M

USD 121.55M

1.8K

EPS每股收益

USD 0.49

股本和储备

USD 1.73B

USD 265.83M

债务利息支出

USD 4.65M

USD 11.94M

USD 285.82M

USD 5.16B

USD 82.76M

USD 1.73B

USD 89.08M

普通股股本

USD 165.1M

USD 14.9

USD 100.74M

USD 394.2M

销售和管理费用

USD 171.77M

USD 191M

贸易债权人

USD 68M

应收帐款人

USD 355.11M

	净收入	更改		日
AbbVie	USD 1.82B		1.63B	2025-12
Acadia Pharmaceuticals	USD 71.78M		45.11M	2025-09
ALKERMES	USD 82.76M		4.34M	2025-09
Amgen	USD 1.33B		1.88B	2025-12
Biogen	USD 466.5M		168.3M	2025-09
BioMarin Pharmaceutical	USD -46.57M		15.83M	2025-12
Bristol-Myers Squibb	USD 1.09B		1.11B	2025-12
Coherus Biosciences	USD -56.57M		5.87M	2025-03
Eli Lilly	USD 6.64B		1.05B	2025-12
Gilead Sciences	USD 2.18B		869M	2025-12
Heron Therapeutics	USD -4.85M		4.39M	2024-09
Ionis Pharmaceuticals	USD -128.61M		252.16M	2025-09
J&J	USD 5.12B		36M	2025-12
Malin Corporation	EUR -1.1M		2.2M	2023-12
Merck	USD 2.96B		2.82B	2025-12
Minerva Neurosciences	USD 1.44M		21.07M	2024-12
Nektar Therapeutics	USD -37.06M		15.31M	2024-09
Neurocrine Biosciences	USD 209.5M		102M	2025-09
Otsuka Holdings	JPY 65.49B		58.64B	2025-12
Ovoca Bio	EUR -5.65M		3.28M	2022-06
Pfizer	USD -1.65B		5.19B	2025-12
Regeneron Pharmaceuticals	USD 844.6M		615.4M	2025-12
Vertex Pharmaceuticals	USD 1.19B		108.2M	2025-12

ALKERMES 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.